Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050492705> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W2050492705 abstract "The development of biocompatible nanoparticles for in-vivo molecular imaging and targeted therapy is an area of considerable current interest across a number of science, engineering, and biomedical disciplines. The basic rationale is that nanometer-sized particles have functional and structural properties that are not available from either discrete molecules or bulk materials. When conjugated with biomolecular targeting ligands such as monoclonal antibodies, peptides or small molecules, these nanoparticles can be used to target malignant tumors with high specificity and affinity. In the “mesoscopic” size range of 10-100 nm diameter, nanoparticles also have large surface areas for conjugating to multiple diagnostic (e.g., optical, radioisotopic, or magnetic) and therapeutic (e.g., anticancer) agents. Recent advances have led to the development of biodegradable nanostructures for drug delivery, iron oxide nanocrystals for magnetic resonance imaging (MRI), quantum dots (QDs) for multiplexed molecular diagnosis and in-vivo imaging, and nanoscale carriers for short-interfering RNA (siRNA) delivery. We have developed biocompatible and nontoxic nanoparticles for in-vivo tumor targeting and detection based on self-assembled nanostructures and pegylated colloidal gold. In particular, colloidal gold has been safely used to treat rheumatoid arthritis for 50 years, and has recently been found to amplify the efficiency of Raman scattering by 14-15 orders of magnitude. Here we show that large optical enhancements can be achieved under in-vivo conditions for tumor detection in live animals. A major finding is that small-molecule Raman reporters such as organic dyes are not displaced but are stabilized by thiol-modified polyethylene glycols. These pegylated SERS nanoparticles are considerably brighter than semiconductor quantum dots with light emission in the near-infrared window. When conjugated to tumor targeting ligands such as single chain variable fragment (ScFv) antibodies, the conjugated nanoparticles are able to target tumor biomarkers such as epidermal growth factor receptors (EGFR) on human cancer cells and in xenograft tumor models." @default.
- W2050492705 created "2016-06-24" @default.
- W2050492705 creator A5022867429 @default.
- W2050492705 creator A5090502166 @default.
- W2050492705 date "2013-01-01" @default.
- W2050492705 modified "2023-10-18" @default.
- W2050492705 title "Spectrally Encoded SERS Nanoparticles for Multiplexed Optical Detection and Image-Guided Surgery" @default.
- W2050492705 doi "https://doi.org/10.1364/n3.2013.nsa2c.1" @default.
- W2050492705 hasPublicationYear "2013" @default.
- W2050492705 type Work @default.
- W2050492705 sameAs 2050492705 @default.
- W2050492705 citedByCount "1" @default.
- W2050492705 countsByYear W20504927052023 @default.
- W2050492705 crossrefType "proceedings-article" @default.
- W2050492705 hasAuthorship W2050492705A5022867429 @default.
- W2050492705 hasAuthorship W2050492705A5090502166 @default.
- W2050492705 hasConcept C104819515 @default.
- W2050492705 hasConcept C136339569 @default.
- W2050492705 hasConcept C150903083 @default.
- W2050492705 hasConcept C155672457 @default.
- W2050492705 hasConcept C16387964 @default.
- W2050492705 hasConcept C171250308 @default.
- W2050492705 hasConcept C182606246 @default.
- W2050492705 hasConcept C192562407 @default.
- W2050492705 hasConcept C207001950 @default.
- W2050492705 hasConcept C26926545 @default.
- W2050492705 hasConcept C2779820397 @default.
- W2050492705 hasConcept C86803240 @default.
- W2050492705 hasConceptScore W2050492705C104819515 @default.
- W2050492705 hasConceptScore W2050492705C136339569 @default.
- W2050492705 hasConceptScore W2050492705C150903083 @default.
- W2050492705 hasConceptScore W2050492705C155672457 @default.
- W2050492705 hasConceptScore W2050492705C16387964 @default.
- W2050492705 hasConceptScore W2050492705C171250308 @default.
- W2050492705 hasConceptScore W2050492705C182606246 @default.
- W2050492705 hasConceptScore W2050492705C192562407 @default.
- W2050492705 hasConceptScore W2050492705C207001950 @default.
- W2050492705 hasConceptScore W2050492705C26926545 @default.
- W2050492705 hasConceptScore W2050492705C2779820397 @default.
- W2050492705 hasConceptScore W2050492705C86803240 @default.
- W2050492705 hasLocation W20504927051 @default.
- W2050492705 hasOpenAccess W2050492705 @default.
- W2050492705 hasPrimaryLocation W20504927051 @default.
- W2050492705 hasRelatedWork W1624797 @default.
- W2050492705 hasRelatedWork W1982563407 @default.
- W2050492705 hasRelatedWork W2069021161 @default.
- W2050492705 hasRelatedWork W2558431542 @default.
- W2050492705 hasRelatedWork W2801959203 @default.
- W2050492705 hasRelatedWork W2850142515 @default.
- W2050492705 hasRelatedWork W2914859618 @default.
- W2050492705 hasRelatedWork W2970467101 @default.
- W2050492705 hasRelatedWork W3023313248 @default.
- W2050492705 hasRelatedWork W3119140696 @default.
- W2050492705 isParatext "false" @default.
- W2050492705 isRetracted "false" @default.
- W2050492705 magId "2050492705" @default.
- W2050492705 workType "article" @default.